Sartorius (OTCMKTS:SARTF – Get Free Report) will likely be releasing its results before the market opens on Thursday, October 22nd. Analysts expect Sartorius to post earnings of $1.42 per share and revenue of $1.01 billion for the quarter.
Sartorius Stock Performance
Shares of SARTF stock opened at $243.86 on Tuesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. Sartorius has a 52-week low of $181.58 and a 52-week high of $243.86. The company has a market capitalization of $8.35 billion, a PE ratio of 113.42 and a beta of 0.98. The business’s fifty day moving average is $225.82 and its 200 day moving average is $218.81.
About Sartorius
Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.
The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.
Further Reading
- Five stocks we like better than Sartorius
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
